Prednimustine
Clinical data | |
---|---|
ATC code | L01AA08 (WHO) |
Identifiers | |
| |
Synonyms | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate |
CAS Number | 29069-24-7 |
PubChem (CID) | 34457 |
ChemSpider | 31708 |
UNII | 9403SIO2S8 |
KEGG | C19512 |
Chemical and physical data | |
Formula | C35H45Cl2NO6 |
Molar mass | 646.64 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Prednimustine is a drug used in chemotherapy. It is the ester formed from two other drugs, prednisolone and chlorambucil.
It can be associated with myoclonus.[1]
See also
References
- ↑ Monnerat C, Gander M, Leyvraz S (January 1997). "A rare case of prednimustine-induced myoclonus". J. Natl. Cancer Inst. 89 (2): 173–4. doi:10.1093/jnci/89.2.173. PMID 8998190.
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.